These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35544633)
1. The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis. Iqbal A; Shafique M; Zahoor MA; Muzammil S; Nawaz Z; Jabbar A; Khurshid M; Hussain R; Islam MA; Almatroudi A; Allemailem KS; Rasool MH; Aslam B J Infect Dev Ctries; 2022 Apr; 16(4):698-704. PubMed ID: 35544633 [TBL] [Abstract][Full Text] [Related]
2. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India. Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand. Pongpeeradech N; Kasetchareo Y; Chuchottaworn C; Lawpoolsri S; Silachamroon U; Kaewkungwal J PLoS One; 2022; 17(7):e0271130. PubMed ID: 35895742 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study. Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148 [TBL] [Abstract][Full Text] [Related]
7. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842 [TBL] [Abstract][Full Text] [Related]
8. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis. Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria. Ikuabe PO; Ebuenyi ID Pan Afr Med J; 2018; 29():204. PubMed ID: 30100958 [TBL] [Abstract][Full Text] [Related]
10. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118 [TBL] [Abstract][Full Text] [Related]
11. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia. Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053 [TBL] [Abstract][Full Text] [Related]
12. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients. Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390 [TBL] [Abstract][Full Text] [Related]
13. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns. Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562 [TBL] [Abstract][Full Text] [Related]
14. Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India. Singh UB; Pandey P; Mehta G; Bhatnagar AK; Mohan A; Goyal V; Ahuja V; Ramachandran R; Sachdeva KS; Samantaray JC PLoS One; 2016; 11(2):e0149258. PubMed ID: 26894283 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China. Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686 [TBL] [Abstract][Full Text] [Related]
16. Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan. Jan F; Wali S; Sadia S; Akbar MT; Akbar HS; Ahmad W; Ahmad M; Khalid A Tuberk Toraks; 2018 Mar; 66(1):26-31. PubMed ID: 30020038 [TBL] [Abstract][Full Text] [Related]
17. Molecular detection of rifampicin resistance by GeneXpert Rahman H; Khan SU; Khan MA; Qasim M; Jabbar A; Noor S; Khan Z; Khan TA; Hussain M; Muhammad N; Ali N J Glob Antimicrob Resist; 2017 Jun; 9():118-120. PubMed ID: 28501582 [TBL] [Abstract][Full Text] [Related]
18. Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia. Erkihun M; Kiros T; Berhan A; Ayele B J Med Microbiol; 2023 Dec; 72(12):. PubMed ID: 38099651 [No Abstract] [Full Text] [Related]
19. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]